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The present study. Despite major improvements in equip-
ment and operator skill, acute vessel closure remains an
important limitation of coronary angioplasty
. occurring_ in
2% to 12% of procedures
(1-5), Localized dissection of the
arterial wall with intimal flap formation, elastic recoil of the
distended arterial segment and thrombosis play central roles
in this complication . In the current issue of the Journal,
Lincoff or at . (6) meticulously describe the outcome of 109
patients with abrupt vessel closure (8 .3%) during 1,319
consecutive coronary angioplasty procedures. Thrombus or
coronary dissection, or both, was identified in 20% and 28%
of cases, respectively . Successful reversal of abrupt vessel
closure could be accomplished in only 43% of the group,
with an 8% incidence of death, 20% need for emergency
coronary bypass surgery and development of Q wave or
non-Q wave infarction in 9% and I1%, respectively .
Factors influencing angioplasty success rate . Of note are
three factors that may have influenced procedural success
rates:
1 . Objective measurements of anticoagulation were not
made with use of activated clotting times ; instead, patients
were given a bolus infusion of heparin, 10 .000 U, followed
by 5,000 U/h . This dose has been shown to he potentially
subtherapeutic (activated clotting time <300 s) in at least
11% of
patients (7) . Microemboli formation has been docu-
mented in the cardiopulmonary bypass circuit when the
activated clotting time is <300 s (8),
At our institution, all
patients receive an initial bolus infusion of 15,000 U or
heparin, and often patients require an additional 5,000 to
10.000 U to reach an activated clotting time or 300 s, even if
they are already receiving heparin .
2. In
The setting of vessel closure, redilaliun by use of
autopcrfhsion catheters was attempted
in only 7 of 109
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patients. Prolonged (>120 s) balloon inflations were made
with standard angioplasty catheters, a technique limited by
ischemia ; use of autoperfusion catheters might have allowed
for more prolonged inflation
(9), further improving the inci-
dence of vessel salvage .
3 . The investigators (6) do not describe an observation
period after the last dilation in each lesion . We have
reported (101 a series of 1,000 consecutive patients who
underwent repeat angiagraphy, 10 min after the last balloon
inflation and found that, in 7% ofcases, repeat dilation was
required because of partial or total loss of the initial gain .
This loss was not related to the initial angiographic result . A
second period of 10 min was allowed before the final
angiographic study . In this series, the incidence of abrupt
vessel closure after patients left the catheterization labora.
!ory was almost nonexistent (<1%), suggesting that repeat
dilation at I0 min may prevent abrupt closure in these
patients with early loss of the initial improvement after
coronary angioplasty.
Treatment of acute coronary closure . A rate of acute
closure similar to that of the Lincoff study (6) was reported
in a study from the National Heart, Lung, and Blood
Institute Angioplasty Registry (1) as well as in other studies
These darn suggest that the need for
emergency
surgical revasealarieatiun after coronary angioplasty is in-
frequent but unpredictable
; for this reason, we believe that
angioplasty should be performed in facilities with the capac-
ity for rapid surgical support .
The unique aspect of this investigation is that, toward the
end of the study period, two new interventions became
available and were applied in the treatment of abrupt closure
in 11 patients . Nine patients had emergency stent deploy-
ment and two patients underwent directional atherectomy
. It
is conceivable that if these devices had been available
earlier, more patients might have had acute vessel salvage .
These mechanical interventions, coupled with newer phar-
macologic treatments, may further improve the safety of
angioplasty.
Role of atherectomy. Directional coronary atherectomy
provides a controlled method for selective removal of ob •
strutting plaque material . This suggests a possible role far
the atherectomy device in the setting ofocclusive dissection.
Scattered reports (11) have documented the benefit of re.
moving discrete occlusive dissection flaps ; however, the
potential for perforation is inherent in this technology, and
case selection has not been defined. Intuitively, its major
impact should occur in limited dissections or in situations
where (here is significant vessel recoil resulting in vessel
closure or suboptimal angiographic results (>50% residual
Slenosis) .
Use of laser balloon angioplasty
. Another initially prom-
ising approach in We treatment of abrupt closure was the use
of laser balloon angioplasty . Laser energy was used to heat
vascular tissue, seating dissections by thermal welding and
reducing elastic recoil. Reis et al. 112) described a success
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rate of 70% in 10 patients with acute angioplasty failure. '[he
failure rate was, in part, attributed to the size or the available
3-mm laser balloon angioplasty catheter, which was nut
optimal for the vessels. This failure rate, coupled with the
high restenosis rate (71% 15 of 7 vessels) had angiographic
restenosis) and the high cost of equipment, has made this
intervention less attractive .
Coronary seeming. The other promising alternative in the
management of acute coronary closure is the use of emer-
gency coronary stenting
. Both Sigwart ct at . (13) and Haude
et aL (14)
have now demonstrated the potential impact of the
emergency implantation of an endoluminal stent for acute
vessel closure. In the studies of Sigwart et al . (13) using the
Medivent Wall scent, 10 patients received a coronary stem
with a 100% implantation success rate with no immediate
deaths, myocardial infarctions or need for emergency sur-
gery . Similarly, Haude et aL
(14) demonstrated a
100%
implantation success rate with the Palmaz-Schatz scent in 15
patients with prominent dissections after angioplasty causing
ischemia. Potency was established by angiography in 14
patients at 24 h ; I patient had a thrombotic occlusion treated
with lytic therapy
. Recently, Fischman et al . (15) also
demonstrated the major impact of
inlracoronary stealing on
dissection,
Of 31 lesions that demonstrated significant inti-
mal dissection after balloon angioplasty, a marked improve-
ment in angiographic appearance with a reduction in the
residual lumen stenosis was noted in >90% after scent
implantation.
Scents are not without certain inherent problems . Herr-
mann et al. (16) reported a 17% subacute thrombotic event
rate for emergency stenting in the setting
of failed angio-
plast ;, a rate twice as high as that demonstrated in elective
placement of stems, To avoid this, the cardiologist can
decide to pursue elective coronary surgery . The ability to
convert an emergency coronary bypass procedure to an
elective one several days later has significant
appeal .
Pbarmaeolegictrealment Additional new pharmacologic
treatment strategies for acute closure after coronary angio-
plasty are being actively pursued . Platelet-rich thrombi are
most commonly observed in patients with occlusion . The
surface of platelets is densely populated with receptors for
adhesion molecules. Most prominent aweng these receptors
is the fibrinogen receptor, glycoprotein Hblllla . The forma-
tion of a platelet thrombus occurs when stimulated platelets
are aggregated by fibrinogen molecules bound at these
glycoprotein llblllla sites. The chimeric 7E3 monoclonal
antibody Fab fragment (c7E3 Fab) selectively binds to the
glycoprotein I1bl1IIa receptor, thereby blocking fibrinogen
binding (17-19). The antibody effectively prevents the bind-
ing of fibrinogen to the platelet surface. Bdcasse 0133 Fab is
a more potent inhibitor of platelet function than is aspirin
(20), greater efficacy in reducing the risk of
thrombotic
occlusion is possible .
Another promising pharmacologic intervention
is hirudin.
Because of
its inhibition of clot-bound thrombin, hirudin
is one of the most potent and selective inhibitors of throm-
sATLER
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bin known . It has been shown to be more effective than
heparin or heparin plus aspirin in the reduction of
platelet-
thrombus
deposition in an experimental angioplasty model
(21) . Its potential role in this syndrome remains to be
explored.
Conclusions. Until the roles of these new mechanical and
pharmacologic alternatives are fully established, acute ves-
sel closure after coronary angioplasty will continue to have
an important impact on final procedural outcome . and the
aced for early surgical standby will persist . Repeat attgiog-
raphy 10 min after final dilation and aggressive monitoring of
anticoagulant status seem advisable, and appear to diminish
the incidence of acute closure .
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